Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- TRY 255.1T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | TRY 501B | TRY 3,314.70 | 4.81% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | TRY 415.9B | TRY 5,999.49 | 2.02% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | TRY 242.5B | TRY 4,306.96 | 1.82% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | TRY 414.7B | TRY 6,353.02 | 1.04% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | TRY 432.1B | TRY 15,457.65 | 0.47% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | TRY 361.8B | TRY 2,597.54 | 0.28% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | TRY 233.9B | TRY 1,404.55 | 3.30% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | TRY 301.3B | TRY 15,062.51 | 1.65% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | TRY 484.2B | TRY 5,099.01 | 7.78% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | TRY 393.2B | TRY 2,339.58 | 2.07% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | TRY 228.8B | TRY 2,090.19 | 1.42% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | TRY 766.6B | TRY 3,935.27 | 1.60% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | TRY 239.4B | TRY 682.10 | 2.63% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | TRY 246.1B | TRY 1,414.64 | 0.72% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | TRY 305.7B | TRY 4,682.18 | 0.97% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | TRY 244.6B | TRY 2,548.12 | 1.13% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | TRY 327B | TRY 4,822.13 | 0.73% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | TRY 253.2B | TRY 3,031.01 | 0.43% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | TRY 472.2B | TRY 20,325.93 | 4.49% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | TRY 799.9B | TRY 12,461.69 | 2.65% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | TRY 375.1B | TRY 3,427.67 | 3.00% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | TRY 309.6B | TRY 2,189.79 | 1.00% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | TRY 266.1B | TRY 6,305.61 | 0.49% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | TRY 598.8B | TRY 3,091.53 | 4.77% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | TRY 198.3B | TRY 1,448.43 | 2.25% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | TRY 676.8B | TRY 1,354.12 | 3.87% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | TRY 1.33T | TRY 6,057.99 | 1.43% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | TRY 1.41T | TRY 1,947.21 | 0.26% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | TRY 356B | TRY 6,768.08 | 1.29% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | TRY 158.3B | TRY 816.00 | 0.43% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | TRY 376.2B | TRY 4,788.09 | 0.18% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | TRY 423.9B | TRY 530.05 | 1.50% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | TRY 368.9B | TRY 4,214.16 | 1.78% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | TRY 895B | TRY 13,643.96 | 0.24% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | TRY 1.24T | TRY 29,211.69 | 0.84% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | TRY 1.76T | TRY 4,328.65 | 2.82% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | TRY 1T | TRY 7,489.27 | 5.11% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | TRY 318.7B | TRY 7,847.60 | 1.34% down | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | TRY 383.2B | TRY 1,099.94 | 3.27% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | TRY 1.19T | TRY 1,038.92 | 0.73% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | TRY 630.5B | TRY 756.24 | 1.39% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | TRY 2.48T | TRY 2,125.74 | 1.10% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | TRY 8.07T | TRY 1,415.90 | 1.39% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | TRY 6.16T | TRY 3,011.85 | 2.66% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | TRY 2.01T | TRY 3,496.00 | 0.93% up | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | TRY 4.93T | TRY 47,689.76 | 1.27% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | TRY 6.87T | TRY 27,106.62 | 0.61% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | TRY 1.59T | TRY 2,585.19 | 1.35% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | TRY 2.33T | TRY 20,379.39 | 2.22% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | TRY 9.13T | TRY 5,271.74 | 0.17% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | TRY 17.08T | TRY 6,927.20 | 4.20% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | TRY 25.45T | TRY 14,397.05 | 2.51% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | TRY 289B | TRY 424.64 | 2.43% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | TRY 8.76T | TRY 1,988.31 | 3.13% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | TRY 62.02T | TRY 69,626.77 | 2.47% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | TRY 4.92T | TRY 2,454.10 | 1.18% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | TRY 33.19T | TRY 13,788.83 | 1.90% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | TRY 5.72T | TRY 2,380.68 | 0.68% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | TRY 14.76T | TRY 7,816.33 | 2.60% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | TRY 13.97T | TRY 9,004.78 | 2.04% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | TRY 3.43T | TRY 1,073.21 | 1.66% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4328 TRY).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of TRY 255.1T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.